Literature DB >> 10777241

The fate of patients with critical leg ischemia.

J Dormandy1, L Heeck, S Vig.   

Abstract

In some highly specialized and aggressive units, 90% of patients with critical leg ischemia (CLI) will undergo some form of surgical or endovascular procedure; however, in most, the figure is nearer 50 to 60%. The primary amputation rate varies from around 10% to 40%. The mortality rate in these patients with standard therapy is around 20% at 1 year and between 40% and 70% at 5 years. Virtually all (95%) patients who present with ischemic gangrene, and 80% of those presenting with rest pain, are dead within 10 years. There appears to be a decline in overall major amputation rates associated with a corresponding increase in revascularizations. However, although technical advances may have resulted in a steadying or even decrease in amputations, comparisons of total amputations over a longer period suggest an increase, presumably attributable to an aging population. Some forward projections predict that major amputations will be doubled in the next 30 years.

Entities:  

Mesh:

Year:  1999        PMID: 10777241

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  48 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

2.  Popliteal-to-distal artery bypass for diabetic limb salvage.

Authors:  A E Brannigan; K Ahmad; M Tubassum; M Clarke Moloney; P A Grace; P E Burke
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

3.  Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.

Authors:  Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos
Journal:  Am J Pathol       Date:  2012-03-21       Impact factor: 4.307

4.  Prevalence of peripheral arterial disease - results of the Heinz Nixdorf recall study.

Authors:  Knut Kröger; Andreas Stang; Jana Kondratieva; Susanne Moebus; Eva Beck; Axel Schmermund; Stefan Möhlenkamp; Nico Dragano; Johannes Siegrist; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

5.  The perfusion index is a useful screening tool for peripheral artery disease.

Authors:  Hiroshi Okada; Muhei Tanaka; Takashi Yasuda; Tadaaki Kamitani; Hisahiro Norikae; Tetsuya Fujita; Takashi Nishi; Hirokazu Oyamada; Tetsuro Yamane; Michiaki Fukui
Journal:  Heart Vessels       Date:  2018-10-03       Impact factor: 2.037

6.  Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.

Authors:  Joseph M McClung; Timothy J McCord; Kevin Southerland; Cameron A Schmidt; Michael E Padgett; Terence E Ryan; Christopher D Kontos
Journal:  J Vasc Surg       Date:  2015-08-05       Impact factor: 4.268

Review 7.  [Patient assessments of quality of life following bypass for chronic critical limb ischaemia].

Authors:  M Engelhardt; W A Wohlgemuth; C Willy; M Tannheimer; K D Wölfle
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 8.  Therapeutic angiogenesis for critical limb ischaemia.

Authors:  Brian H Annex
Journal:  Nat Rev Cardiol       Date:  2013-05-14       Impact factor: 32.419

9.  Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.

Authors:  Hyung-Jun Im; Christopher G England; Liangzhu Feng; Stephen A Graves; Reinier Hernandez; Robert J Nickles; Zhuang Liu; Dong Soo Lee; Steve Y Cho; Weibo Cai
Journal:  ACS Appl Mater Interfaces       Date:  2016-07-07       Impact factor: 9.229

10.  Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities.

Authors:  I Vaartjes; G J de Borst; J B Reitsma; A de Bruin; F L Moll; D E Grobbee; M L Bots
Journal:  BMC Cardiovasc Disord       Date:  2009-08-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.